• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

HADES Clinical Score Demonstrates Consistent Discriminative Accuracy for Hereditary Angioedema Screening

by
November 12, 2026
in Health
Reading Time: 2 mins read
0
HADES Clinical Score Demonstrates Consistent Discriminative Accuracy for Hereditary Angioedema Screening

HADES Clinical Score Demonstrates Consistent Discriminative Accuracy for Hereditary Angioedema Screening

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A temporal validation study evaluating the predictive clinical score known as HADES has reproduced the discriminative performance of its original derivation model in identifying patients with suspected hereditary angioedema due to C1 inhibitor deficiency. Researchers observed an area under the receiver operating characteristic curve of 0.80, with a 95 percent confidence interval spanning from 0.73 to 0.86, matching the diagnostic performance documented in the initial derivation dataset.

Hereditary angioedema due to C1 inhibitor deficiency, designated as HAE-C1-INH, is frequently misdiagnosed in clinical settings, a problem that leads to delayed diagnosis and inappropriate clinical management. To address these diagnostic delays, investigators previously developed the HADES clinical scoring system as a predictive mechanism designed to support the early identification of individuals at risk for the condition.

To assess the temporal performance of the predictive score and explore the practical feasibility of digital delivery, the researchers evaluated a new cohort comprising 539 individuals presenting with suspicion of HAE-C1-INH. Numerical HADES scores were calculated for all participants in the validation cohort using previously predefined score thresholds to ensure standardized comparison with the derivation dataset.

The validation cohort successfully reproduced the key performance characteristics identified during the development of the scoring tool. Sensitivity remained at 100 percent when evaluated at low score thresholds, while diagnostic specificity demonstrated a progressive increase across higher score categories. Furthermore, the analysis confirmed that zero confirmed cases of HAE-C1-INH occurred within score category 0.

In parallel with the primary cohort analysis, the investigators conducted a prospective pilot study involving 18 patients to evaluate the implementation feasibility of a mobile digital platform designated as the HADES App. This exploratory digital cohort generated preliminary observational information regarding the feasibility of deploying the predictive scoring algorithm within clinical workflows.

In addition, six patients with HAE-FXII were analyzed separately for exploratory purposes. Analysis of this subgroup revealed that individuals with HAE-FXII displayed clinical score distributions that overlapped with the score distributions observed among confirmed HAE-C1-INH cases.

The authors concluded that the temporal validation cohort confirms discriminative performance consistent with the original study and provides reasonable overall category-level calibration. These findings support the potential role of HADES as a clinical screening tool for HAE-C1-INH, while indicating that preliminary findings from the digital application warrant further prospective evaluation.

Subject of Research: Temporal validation and digital app implementation of the HADES predictive score for hereditary angioedema

Article Title: Validation and digital implementation of the HADES score for hereditary angioedema

Article References: Zwiener, R. D., Castro Labrador, L., Zamora, R., Galmarini, C. M., Brion, L., Pino, A., & Rozenfeld, P. (2026). Validation and digital implementation of the HADES score for hereditary angioedema. Frontiers in Epidemiology, 6, 2000978. https://doi.org/10.3389/fepid.2026.2000978

Image Credits: AI Generated

DOI: 10.3389/fepid.2026.2000978

Keywords: Hereditary angioedema, HAE-C1-INH, HADES score, Clinical screening tool, Predictive clinical score, Temporal validation cohort, ROC analysis, Area under the curve, Diagnostic performance, Clinical decision support, Digital health implementation, HADES App, HAE-FXII, C1 inhibitor deficiency, Clinical epidemiology, Sensitivity and specificity

News Source: Ophelia Keating. (November 12, 2026). HADES Clinical Score Demonstrates Consistent Discriminative Accuracy for Hereditary Angioedema Screening. Scienmag.

Tags: area under the curveC1-inhibitor deficiencyClinical decision supportclinical epidemiologyClinical screening toolDiagnostic PerformanceDigital health implementationHADES AppHADES scoreHAE-C1-INHHAE-FXIIhereditary angioedemaPredictive clinical scoreROC analysissensitivity and specificityTemporal validation cohort
Share12Tweet7Share2ShareShareShare1

Related Posts

Wearable Exoskeleton Accurately Quantifies Upper Limb Motor Impairment After Stroke

Wearable Exoskeleton Accurately Quantifies Upper Limb Motor Impairment After Stroke

November 19, 2026
Cardiac MRI and Ultrasound Strain Measures Differ in Chronic Ischemic Disease

Cardiac MRI and Ultrasound Strain Measures Differ in Chronic Ischemic Disease

November 19, 2026

Mathematical Formulas for Ventilator Energy Show Wide Discrepancies in Intensive Care

November 19, 2026

Network Meta-Analysis Compares Janus Kinase Inhibitors and Adalimumab in Psoriatic Arthritis

November 19, 2026

POPULAR NEWS

  • East Hararghe Farmers Show Mixed Perceptions Toward Irrigated Cluster Wheat Farming

    East Hararghe Farmers Show Mixed Perceptions Toward Irrigated Cluster Wheat Farming

    29 shares
    Share 12 Tweet 7
  • Fruit and Vegetable Consumption Declined Among Iranian Adults With Hypertension Over 15 Years

    29 shares
    Share 12 Tweet 7
  • Multiscale Fusion Dehazing Algorithm Preserves Sharp Edges in Foggy Driving Vision

    29 shares
    Share 12 Tweet 7
  • Periorbital Anthrax Mimicked Necrotizing Infection Following Soil Trauma in Case Report

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Wearable Exoskeleton Accurately Quantifies Upper Limb Motor Impairment After Stroke

Cardiac MRI and Ultrasound Strain Measures Differ in Chronic Ischemic Disease

Mathematical Formulas for Ventilator Energy Show Wide Discrepancies in Intensive Care

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.